What is Riverain Technologies?
Founded in 2004 and headquartered in Miamisburg, Ohio, Riverain Technologies operates at the intersection of medical imaging and artificial intelligence. The company specializes in developing sophisticated software tools designed to assist clinicians in the early detection of lung disease. By streamlining the diagnostic workflow, Riverain provides essential support for healthcare providers aiming to improve patient survival rates through timely intervention. Their market position is defined by a long-standing commitment to thoracic imaging precision, establishing them as a critical player in the diagnostic technology sector.
How much funding has Riverain Technologies raised?
Riverain Technologies has raised a total of $8.3M across 1 funding round:
Stock/Share Issuance
$8.3M
Stock/Share Issuance (2026): $8.3M, investors not publicly disclosed
Key Investors in Riverain Technologies
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Riverain Technologies?
With this major enterprise-level funding, Riverain Technologies is poised to scale its operational capacity and expand its footprint within the global healthcare market. The strategic allocation of this capital will likely focus on the refinement of their proprietary imaging algorithms and the broadening of their clinical application suite. As the demand for automated diagnostic support grows, Riverain is strategically aligned to leverage its established expertise to capture further market share, potentially exploring new partnerships or regulatory pathways to integrate their technology into broader clinical environments.
See full Riverain Technologies company page
